Schedule Z of the Drugs & Cosmetics Act for ASU Drugs

Schedule Z of the Drugs & Cosmetics Act for ASU Drugs explains regulatory requirements quality standards and documentation for ASU medicines.

Schedule Z of the Drugs & Cosmetics Act for ASU Drugs

• Schedule Z outlines regulatory requirements for conducting clinical trials on Ayurvedic, Siddha, and Unani (ASU) medicines to ensure their safety, efficacy, and therapeutic value through systematic research.

Purpose and Scope

• Introduced to promote scientifically validated clinical studies on ASU drugs.
• Ensures standardized protocols for evaluating safety, efficacy, and therapeutic benefits.

Key Guidelines Under Schedule Z

1. Clinical Trial Protocols

   • Must follow scientifically accepted methodologies and ethical standards.
   • Protocols should define objectives, patient selection criteria, dosage, study duration, outcome measures, and evaluation criteria.

2. Ethical Clearance

   • Trials must be reviewed and approved by Institutional Ethics Committees (IEC) registered with the Ministry of AYUSH or other competent authorities.

3. Informed Consent

   • Written informed consent is mandatory for all participants.
   • Participants must be informed about the trial objectives, potential benefits, risks, and procedures.

4. Clinical Trial Phases (for ASU drugs)

   • Schedule Z classifies trials into four phases, similar to modern medicine trials:

     1. Phase I (Safety Assessment):

        • Tests safety, tolerability, and dosage in a small group of healthy volunteers.
        • Phase II (Exploratory/Preliminary Efficacy):
        • Evaluates therapeutic efficacy, optimal dosage, and preliminary safety in patients.

     2. Phase III (Confirmatory Trials):

        • Conducted on a larger patient population to confirm safety and effectiveness.

     3. Phase IV (Post-Marketing Surveillance):

        • Monitors long-term effects, rare adverse reactions, and real-world effectiveness.

5. Documentation and Reporting

   • Detailed documentation of trial procedures, observations, results, and adverse reactions.
   • Clinical trial data must be submitted to regulatory authorities for approval and registration

Click Here to Watch the Best Pharma Videos